Related Experiment Videos
Response letter to Drs. Halperin and Greenberg
Gary P Wormser1, Franc Strle2, Eugene D Shapiro3
1Division of Infectious Diseases, New York Medical College, Valhalla, NY 10595.
Diagnostic Microbiology and Infectious Disease
|February 28, 2017
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Human Cases of Borrelia miyamotoi Disease, Slovenia, 2025.
Emerging infectious diseases·2026
Characterization of Anti-Phospholipid Antibodies in Lyme Borreliosis Using In-House Developed ELISAs.
Antibodies (Basel, Switzerland)·2026
Emerging human pathogen: Identifying Spiroplasma ixodetis as a frequent cause of unlocalised febrile illness.
The Journal of infection·2026
Clinical Manifestations of Lyme Borreliosis in Europe: Burden of Lyme Disease Study (BOLD), 2021-2022.
Pathogens (Basel, Switzerland)·2026
Lyme borreliosis.
Nature reviews. Disease primers·2026
Development and analytical validation of nanoparticle-enhanced immunochromatographic assay for rapid detection of hepatitis C antibodies.
Diagnostic microbiology and infectious disease·2026
Diagnostic accuracy of bronchoalveolar lavage fluid-based testing for pulmonary cryptococcosis: A systematic review and meta-analysis.
Diagnostic microbiology and infectious disease·2026
Historical series of paracoccidioidomycosis ocular cases (1923-2025): emphasis on molecular diagnosis of P. lutzii in Midwestern Brazil.
Diagnostic microbiology and infectious disease·2026
One health, one goal: Global imperatives for Nipah virus vaccine development.
Diagnostic microbiology and infectious disease·2026
Whole genome sequencing of unusual Hepatitis C virus subtypes and drug resistance analysis during direct-acting antiviral therapy in India.
Diagnostic microbiology and infectious disease·2026
Associations of Cholesin and GPR146 with atherosclerotic plaque stability: integrated bioinformatics and functional analyses.
Frontiers in cardiovascular medicine·2026
Caveolin-1 levels associated with coronary artery disease in Chinese participants: a retrospective cohort study.
Frontiers in cardiovascular medicine·2026
PCSK9 inhibitors for lipid-lowering treatment in patients with atherosclerotic cardiovascular disease: a health technology assessment.
Frontiers in cardiovascular medicine·2026